No abstract
Transplant Cell Ther. 2026 Oct 14:S2666-6367(26)00763-3. doi: 10.1016/j.jtct.2026.09.032. Online ahead of print.
NO ABSTRACT
PMID:42874682 | DOI:10.1016/j.jtct.2026.09.032
Corrigendum to "Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients"
Scritto il 14/10/2026
da Lilit Karapetyan